TY  - GEN
AU  - Giuliano,Mario
AU  - Schettini,Francesco
AU  - Rognoni,Carla
AU  - Milani,Manuela
AU  - Jerusalem,Guy
AU  - Bachelot,Thomas
AU  - De Laurentiis,Michelino
AU  - Thomas,Guglielmo
AU  - De Placido,Pietro
AU  - Arpino,Grazia
AU  - De Placido,Sabino
AU  - Cristofanilli,Massimo
AU  - Giordano,Antonio
AU  - Puglisi,Fabio
AU  - Pistilli,Barbara
AU  - Prat,Aleix
AU  - Del Mastro,Lucia
AU  - Venturini,Sergio
AU  - Generali,Daniele
TI  - Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
SN  - 1474-5488
PY  - 2020///0622
KW  - Aminopyridines
KW  - administration & dosage
KW  - Anastrozole
KW  - Androstadienes
KW  - Antineoplastic Agents, Hormonal
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Benzimidazoles
KW  - Bevacizumab
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Clinical Trials, Phase II as Topic
KW  - Clinical Trials, Phase III as Topic
KW  - Everolimus
KW  - Female
KW  - Fulvestrant
KW  - Humans
KW  - Letrozole
KW  - Network Meta-Analysis
KW  - Paclitaxel
KW  - Piperazines
KW  - Postmenopause
KW  - Progression-Free Survival
KW  - Purines
KW  - Pyridines
KW  - Randomized Controlled Trials as Topic
KW  - Receptor, ErbB-2
KW  - metabolism
KW  - Receptors, Estrogen
KW  - Receptors, Progesterone
N1  - Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Systematic Review
UR  - https://doi.org/10.1016/S1470-2045(19)30420-6
ER  -